QTc Cutoff for Haloperidol Administration

Understanding QTc Prolongation Risk

• A QTc of 500 ms or greater in either sex correlates with significantly higher risk for developing torsades de pointes, a potentially fatal ventricular arrhythmia 2, 3
• Reported cases of drug-induced torsades de pointes indicate that the vast majority occur in patients with QTc ≥500 ms 2
• Haloperidol causes QT prolongation of approximately 7 ms on average, but this effect can be greater in vulnerable patients 4

Risk Assessment Before Haloperidol Administration

Baseline QTc Evaluation

• Obtain baseline ECG before administering haloperidol to document initial QTc interval 5
• Normal QTc values are ≤460 ms for women and ≤450 ms for men 2, 3
• Document QTc including rhythm strip in patient's medical record at baseline 5

Risk Factors for QTc Prolongation

• Avoid haloperidol in patients with baseline QTc prolongation 1
• Avoid haloperidol in patients with concomitant medications known to prolong QT interval 1, 4
• Avoid haloperidol in patients with a history of torsades de pointes 1

Monitoring Recommendations

• For patients receiving haloperidol, document QTc at baseline and then at least every 8-12 hours 5
• More frequent monitoring may be needed if QTc prolongation occurs during administration 5
• Document QTc before and after increases in haloperidol dose 5
• If QTc exceeds 500 ms during treatment, discontinue haloperidol and continue QTc monitoring until the drug washes out and QTc is documented to be decreasing 5

Route of Administration Considerations

• Intramuscular administration of antipsychotics is the preferred parenteral route in emergency settings 4
• Intravenous haloperidol carries an FDA warning due to deaths associated with high doses and IV administration 4

Alternative Approaches

• For agitation or delirium in patients with prolonged QTc, consider dexmedetomidine (for ICU patients with delirium) 1
• For agitation or delirium in patients with prolonged QTc, consider olanzapine (has less QT prolongation than haloperidol) 4
• For agitation or delirium in patients with prolonged QTc, consider aripiprazole (minimal QT prolongation) 4

Clinical Pitfalls to Avoid

• Failing to obtain baseline ECG before haloperidol administration 5
• Not considering drug interactions that may increase QTc prolongation risk 1, 4
• Continuing haloperidol despite QTc prolongation beyond 500 ms 5